Hearing Loss, Bilateral or Unilateral

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Oticon
OticonDenmark - Smørum
1 program
Transcutaneous bone conduction hearing systemN/A1 trial
Active Trials
NCT07161154Not Yet RecruitingEst. Dec 2035

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
2029
2030
2031
OticonTranscutaneous bone conduction hearing system

Clinical Trials (1)

NCT07161154OticonTranscutaneous bone conduction hearing system

Sentio Systematic Evaluation

Start: Sep 2025Est. completion: Dec 2035
N/ANot Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space